Omagine

OMAGQ · OTC

$0.0002+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About OMAGQ

Omagine, Inc. is a holding company, which engages in the tourism and real estate businesses. The company is headquartered in New York City, New York. The firm is focused on entertainment, hospitality and real estate development opportunities in the Middle East and North Africa (the MENA Region), and on the design and development of tourism destinations. The firm conducts its operations through its subsidiary, Omagine LLC, an Omani limited liability corporation (LLC) and its subsidiary, Journey of Light, Inc. (JOL). Omagine organized Omagine LLC to design, develop, own and operate its initial project, a mixed-use tourism and real estate project named the Omagine Project. The Omagine Project is being developed on one million square meters (equal to 100 hectares or approximately 245 acres) of beachfront land facing the Gulf of Oman, west of Oman's capital city of Muscat and approximately six miles from Muscat International Airport.

Employees
5
Headquarters
New York City, New York
Listed
Feb 29, 1988
Sector
Real Estate
Industry
Real Estate Management & Development

Leadership

Omagine executives
NameTitleSince
Frank Drohan—1991
William Hanley——
Charles Kuczynski—1996
Alan Matus——
Jack Smith——
Louis Lombardo——

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Omagine suppliers and customers
CompanyRelationshipCorrelation
Consolidated Contractors Group SALSupplier and customer—
OmanSupplier and customer—

Similar companies

Companies in the same industry as Omagine

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.